"Nepal needs mass cervical screening":
This article was originally published in Clinica
Executive Summary
Mass screening, research and awareness" at the community level is needed for the high incidence of cervical cancer in Nepal. So said Sheela Verma, chief consultant gynaecologist at Stupa Community Hospital (SCH) in Boudha, a suburb of Kathmandu and a famous pilgrimage/tourist site. A recent screening programme undertaken by the Nepal Network for Cancer Treatment and Research (NNCTR) screened 19,000 women. 955 women were found to have gynaecological malignancies, and 825 had the disease. Further screening is currently underway at the SCH.
You may also be interested in...
Keep Makena Under Accelerated Approval Pending More Studies, AMAG Tells US FDA
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
World-First Nod For Yuhan's Lung Cancer Drug, In Korea
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes Gains US FDA Clearance For Velys Robot For Total Knee Surgery
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: